New antibody aims to supercharge immune system against cancer
Disease control
Recruiting now
This early-stage trial tests a new drug called MST-0312, designed to help the body's immune system fight cancer more effectively. It is being studied alone or with another cancer drug (pembrolizumab) in people with several types of solid tumors, including lung, melanoma, bladder,…
Phase: PHASE1 • Sponsor: Mestag Therapeutics Limited • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC